mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
0.068 |
0.1 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
blebbistatin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.077 |
0.1 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.086 |
0.1 |